Federico Franchi

University of Siena

Papers

1

Total Citations

35

H-Index

1

About

Federico Franchi is a leading thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment. His landmark work centers on comparing robotic-assisted thoracoscopic surgery (RATS) with video-assisted thoracoscopic surgery (VATS) for lobectomy, a critical procedure in early-stage lung cancer management. Franchi’s most influential contribution is a monocentric prospective randomized trial that directly evaluates the efficacy and safety of these two approaches, providing high-quality evidence to guide surgical decision-making. This study, published in 2023 and already garnering 35 citations, highlights his commitment to rigorous clinical research that translates into improved patient outcomes. By systematically analyzing operative outcomes, recovery times, and complication rates, Franchi has helped clarify the relative benefits of robotic assistance in thoracic surgery. His work not only informs surgical practice but also shapes the ongoing debate about technology adoption in operating rooms. Through this pivotal trial, Franchi has established himself as a key voice in the evolution of lung cancer surgery, demonstrating how comparative effectiveness research can drive innovation while maintaining patient-centered care.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
RoboticAssisted (RATS) versus Video-Assisted (VATS) lobectomy: A monocentric prospective randomized trial
35 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: University of Siena

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago